AU2003287188A1 - Activation of hcv-specific cells - Google Patents

Activation of hcv-specific cells

Info

Publication number
AU2003287188A1
AU2003287188A1 AU2003287188A AU2003287188A AU2003287188A1 AU 2003287188 A1 AU2003287188 A1 AU 2003287188A1 AU 2003287188 A AU2003287188 A AU 2003287188A AU 2003287188 A AU2003287188 A AU 2003287188A AU 2003287188 A1 AU2003287188 A1 AU 2003287188A1
Authority
AU
Australia
Prior art keywords
hcv
activation
specific cells
cells
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003287188A
Other versions
AU2003287188A8 (en
Inventor
Steve Coates
Michael Houghton
Xavier Paliard
Mark Selby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Novartis Vaccines and Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US28134102A priority Critical
Priority to US10/281,341 priority
Application filed by Novartis Vaccines and Diagnostics Inc filed Critical Novartis Vaccines and Diagnostics Inc
Priority to PCT/US2003/033610 priority patent/WO2004039950A2/en
Publication of AU2003287188A8 publication Critical patent/AU2003287188A8/en
Publication of AU2003287188A1 publication Critical patent/AU2003287188A1/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
    • C12N2770/00011MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU2003287188A 2002-10-25 2003-10-24 Activation of hcv-specific cells Abandoned AU2003287188A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US28134102A true 2002-10-25 2002-10-25
US10/281,341 2002-10-25
PCT/US2003/033610 WO2004039950A2 (en) 2002-10-25 2003-10-24 Activation of hcv-specific cells

Publications (2)

Publication Number Publication Date
AU2003287188A8 AU2003287188A8 (en) 2004-05-25
AU2003287188A1 true AU2003287188A1 (en) 2004-05-25

Family

ID=32228760

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003287188A Abandoned AU2003287188A1 (en) 2002-10-25 2003-10-24 Activation of hcv-specific cells

Country Status (4)

Country Link
EP (1) EP1576125A4 (en)
AU (1) AU2003287188A1 (en)
CA (1) CA2505611A1 (en)
WO (1) WO2004039950A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60044236D1 (en) 1999-02-17 2010-06-02 Csl Ltd Immunogenic complex and methods with respect to these
NZ543343A (en) * 2003-04-25 2008-03-28 Novartis Vaccines & Diagnostic Compositions comprising cationic microparticles and HCV E1E2 DNA and methods of use thereof
AU2005245909B2 (en) * 2004-05-17 2010-05-27 Novartis Vaccines And Diagnostics, Inc. Truncated hepatitis C virus NS5 domain and fusion proteins comprising same
KR100958505B1 (en) * 2004-07-18 2010-05-17 씨에스엘 리미티드 Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
EP2061888A2 (en) 2006-08-25 2009-05-27 Novartis AG Hcv fusion polypeptides
US9551714B2 (en) 2010-06-25 2017-01-24 Abbott Laboratories Materials and methods for assay of anti-hepatitis C virus (HCV) antibodies
CN103819565B (en) * 2014-02-26 2016-11-09 广州万孚生物技术股份有限公司 Hcv recombinant fusion antigens and gene expression and preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712087A (en) * 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
US5747239A (en) * 1990-02-16 1998-05-05 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
US6153378A (en) * 1992-10-16 2000-11-28 Bionova Corporation Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
DK0935662T3 (en) * 1996-05-24 2006-03-06 Chiron Corp A fusion protein with multiple epitopes
CA2491508A1 (en) * 2002-07-02 2004-01-15 Chiron Corporation Hcv fusion proteins with modified ns3 domains

Also Published As

Publication number Publication date
WO2004039950A2 (en) 2004-05-13
AU2003287188A8 (en) 2004-05-25
WO2004039950A3 (en) 2007-11-22
CA2505611A1 (en) 2004-05-13
EP1576125A4 (en) 2008-09-03
EP1576125A2 (en) 2005-09-21

Similar Documents

Publication Publication Date Title
EP1557827B8 (en) Voice intensifier
AU2003298544A1 (en) Embedded mode converter
EP1284583A3 (en) Cell selection
AU2003282548A1 (en) Nano-chem-fet based biosensors
AU2003221708A1 (en) Hybrid stent
AU2003236906A1 (en) Catalyst
AU2003296586A1 (en) Pyridazinone derivatives as cdk2-inhibitors
AU2003286894A1 (en) Hydrogen generator
AU2003240093A1 (en) Lancet
AU2003251798A1 (en) Battery
AU2003240440A1 (en) Power converter
AU2003213065A1 (en) Novel insect cell line
AU2003229246A1 (en) Outsole
AU2003210921A1 (en) Orthosontic adhesives
AU2003286006A1 (en) Cyclotron
AU2003210075A1 (en) Electromechanical converter
AU2002320273A1 (en) Power converter
AU2003301638A1 (en) Improved energy devices
AU2003262857A1 (en) Selective feature activation
AU2003288586A1 (en) Electrode arrangement
AU2003238635A1 (en) Inverter
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
AU2002352768A1 (en) Multifunctional world-wide-walkie-talkie
AU2003252586A1 (en) Individual cryptoprotective complex
AU2003224632A1 (en) Hppars activators

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase